Citation Impact

Citing Papers

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma
1998
Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning
2013
Mutant G-protein-coupled receptors as a cause of human diseases
2004
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Brain-Controlled Interfaces: Movement Restoration with Neural Prosthetics
2006
The Vienna classification of gastrointestinal epithelial neoplasia
2000 Standout
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Resection of Hepatocellular Carcinoma Without Cirrhosis
2012
Hepatic stellate cells as key target in liver fibrosis
2017
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
2008
Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium
2014
Response of brain tissue to chronically implanted neural electrodes
2005
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008 Standout
Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility
2003
Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods
1999
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Histopathology of Non-Alcoholic Fatty Liver Disease
2009
Rapid adaptive optical recovery of optimal resolution over large volumes
2014 StandoutNobel
Cushing's syndrome
2015 Standout
PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release
2002
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
2006
Hepatocellular carcinoma
2021 Standout
5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers
2007
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
2014
Synthesis of polycaprolactone: a review
2009 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The brain tissue response to biodegradable poly(methylidene malonate 2.1.2)-based microspheres in the rat
2006
American Gastroenterological Association Technical Review on the Role of the Gastroenterologist in the Management of Esophageal Carcinoma
2005
The NAFLD fibrosis score
2007 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Macrophages and Metabolism in the Tumor Microenvironment
2019
Portal hypertensive bleeding in cirrhosis
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists
2000
Morphometrical Characterization of Two Glioma Models in the Brain of Immunocompetent and Immunodeficient Rats
1999
Remote ischemic preconditioning confers late protection against myocardial ischemia–reperfusion injury in mice by upregulating interleukin-10
2012
A novel panel of blood markers to assess the degree of liver fibrosis†
2005
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Routine breath-hold gradient echo MRI-derived right ventricular mass, volumes and function: accuracy, reproducibility and coherence study
2004
Barium Enema and Endoscopy for the Detection of Colorectal Neoplasia: Sensitivity, Specificity, Complications and its Determinants
2001
FIB-4
2007 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Mesoporous Materials for Drug Delivery
2007 Standout
Poly-ϵ-caprolactone microspheres and nanospheres: an overview
2004
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
On the mechanisms of biocompatibility
2008 Standout
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D
2006
Reach and grasp by people with tetraplegia using a neurally controlled robotic arm
2012 StandoutNature
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study
2010
Noninvasive Measures of Liver Fibrosis
2006
Extracellular DNA traps in inflammation, injury and healing
2019
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards
2014
A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart
2011
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease
2003
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C
2009
Management of Crohn's Disease in Adults
2009 Standout
Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction
2009
Adaptive optics confocal microscopy using direct wavefront sensing
2011
Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis
2013
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis
2018
Nanoencapsulation, Nano-guard for Pesticides: A New Window for Safe Application
2016 Standout
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
2021 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Biodegradable polymers as biomaterials
2007 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
2011 Standout
Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection
2005
Pharmacogenomic and Structural Analysis of Constitutive G Protein–Coupled Receptor Activity
2006
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
In vitro and in vivo toxicity of magnetic microspheres
1999
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy
2020
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
2012
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Novel Strategies to Improve the Anticancer Action of 5-Fluorouracil by Using Drug Delivery Systems
2008
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Development Strategies and Prospects of Nano-based Smart Pesticide Formulation
2017 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease
2016

Works of Anne Croué being referenced

Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy?
1997
Fate and biocompatibility of three types of microspheres implanted into the brain
1994
Sources of variability in histological scoring of chronic viral hepatitis†
2005
A Chorionic Gonadotropin–Sensitive Mutation in the Follicle-Stimulating Hormone Receptor as a Cause of Familial Gestational Spontaneous Ovarian Hyperstimulation Syndrome
2003
A Case of Colonic Pseudolipomatosis: A Rare Complication of Colonoscopy?
1997
The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27
2016
Experimental validation of an automated edge‐detection method for a simultaneous determination of the endocardial and epicardial borders in short‐axis cardiac MR images: Application in normal volunteers
1998
RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning
2011
Effect of Stereotactic Implantation of Biodegradable 5-Fluorouracil-loaded Microspheres in Healthy and C6 Glioma-bearing Rats
1996
IL-26 Confers Proinflammatory Properties to Extracellular DNA
2017
Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling
2010
[Overexpression of protein p53 and Barrett esophagus. A frequent and early event in the course of carcinogenesis].
1995
IL‐34 and macrophage colony‐stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells
2014
Addition of Plasma Exchange to Glucocorticosteroids for the Treatment of Severe Henoch-Schönlein Purpura in Adults: A Case Series
2012
Rankless by CCL
2026